Literature DB >> 16685579

Associations between RAS Gene polymorphisms, environmental factors and hypertension in Mongolian people.

Wang Gui-yan1, Wang Yan-hua, Xu Qun, Tong Wei-jun, Gu Ming-ling, Wang Jian, Fang Ming-wu, Zhang Yong-hong.   

Abstract

OBJECTIVE: To explore the association between RAS system genes (AGT, ACE and AT(1)R) polymorphisms, environmental factors and hypertension in Mongolian people.
METHODS: On the basis of cross-sectional study, a case-control study with 299 hypertensives and 281 nomotensives was conducted, and the conditions of environmental factors were acquired by questionnaire. Serum lipid and insulin were detected by using biochemical experiments. Six single nucleotide polymorphisms of RAS system were genotyped by polymerase chain reaction/restriction fragment length polymorphism and polymerase chain reaction/single strand conformation polymorphism.
RESULTS: Overweight or obesity, high serum TG and insulin resistance were risk factors of hypertension by single factor analysis. All the RAS genotype distributions were compatible with Hardy-Weinberg expectations. There were no significant differences to be found between cases and controls for genotype frequencies or allele frequencies of the six polymorphisms of RAS system, except in men group, OR value of men carried ACE ID+DD genotype vs. men carried II genotype was 2.20 (95%CI 1.21-4.02), and OR of people who carried both ACE ID (or DD) and AGT M235T MT (or MM) vs. people with both ACE ID (or DD) and AGT M235T TT was 1.59 (95%CI 1.06-2.38).
CONCLUSIONS: Overweight or obesity, dyslipidemia and insulin resistance were risk factors of hypertension in Mongolian people. ACE gene ID+DD genotype was the risk factor of hypertension in men group. People who carried both ACE ID (or DD) and AGT M235T MT (or MM) had more risk to have hypertension.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685579     DOI: 10.1007/s10654-005-6006-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  The value of isolated populations.

Authors:  S Shifman; A Darvasi
Journal:  Nat Genet       Date:  2001-08       Impact factor: 38.330

2.  Different alcohol drinking and blood pressure relationships in France and Northern Ireland: The PRIME Study.

Authors:  P Marques-Vidal; D Arveiler; A Evans; P Amouyel; J Ferrières; P Ducimetière
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

3.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

Authors:  E A Anderson; R P Hoffman; T W Balon; C A Sinkey; A L Mark
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  The effects of glucose and insulin on renal electrolyte transport.

Authors:  R A DeFronzo; M Goldberg; Z S Agus
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

5.  Angiotensin II type 1 receptor gene polymorphisms in patients with cardiac hypertrophy.

Authors:  A Ishanov; H Okamoto; M Watanabe; K Yoneya; I Nakagawa; H Kumamoto; S Chiba; A Hata; H Kawaguchi; A Kitabatake
Journal:  Jpn Heart J       Date:  1998-01

6.  Genetic and environmental influences on blood pressure in elderly twins.

Authors:  Y Hong; U de Faire; D A Heller; G E McClearn; N Pedersen
Journal:  Hypertension       Date:  1994-12       Impact factor: 10.190

7.  Hypertension genes are genetic markers for insulin sensitivity and resistance.

Authors:  Xiuqing Guo; Suzanne Cheng; Kent D Taylor; Jinrui Cui; Randall Hughes; Manuel J Quiñones; Isabel Bulnes-Enriquez; Roxana De la Rosa; George Aurea; Huiying Yang; Willa Hsueh; Jerome I Rotter
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

8.  Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring.

Authors:  H Y Wu; Y Y Jeng; C J Yue; K Y Chyu; W A Hsueh; T M Chan
Journal:  Diabetes       Date:  1994-08       Impact factor: 9.461

9.  Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele.

Authors:  Chia-Ti Tsai; Daniele Fallin; Fu-Tien Chiang; Juey-Jen Hwang; Ling-Ping Lai; Kuan-Lih Hsu; Chuen-Den Tseng; Chiau-Suong Liau; Yung-Zu Tseng
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

10.  Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes.

Authors:  Alexandre C Pereira; Glória F A Mota; Roberto S Cunha; Fernando L Herbenhoff; José G Mill; José E Krieger
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

View more
  5 in total

1.  Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis.

Authors:  L K Wei; S Menon; L R Griffiths; S H Gan
Journal:  J Hum Hypertens       Date:  2014-07-24       Impact factor: 3.012

Review 2.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review.

Authors:  Amy K Mottl; David A Shoham; Kari E North
Journal:  Genet Med       Date:  2008-08       Impact factor: 8.822

3.  A-6G and A-20C polymorphisms in the angiotensinogen promoter and hypertension risk in Chinese: a meta-analysis.

Authors:  Wei Gu; Jielin Liu; Qiuli Niu; Hao Wang; Yuqing Lou; Kuo Liu; Lijuan Wang; Zuoguang Wang; Jingmei Zhang; Shaojun Wen
Journal:  PLoS One       Date:  2011-12-28       Impact factor: 3.240

4.  Allele, Genotype and Haplotype Structures of Functional Polymorphic Variants in Endothelial Nitric Oxide Synthase (eNOS), Angiotensinogen (ACE) and Aldosterone Synthase (CYP11B2) Genes in Healthy Pregnant Women of Indian Ethnicity.

Authors:  Anichavezhi Devendran; Sreekala Nampoothiri; Deepak Gopal Shewade; Suvro Chatterjee; Balachandar Jayaraman; Adithan Chandrasekharan
Journal:  J Reprod Infertil       Date:  2015 Oct-Dec

5.  Association of angiotensin converting enzyme gene insertion/deletion polymorphism with essential hypertension in south Indian population.

Authors:  Ramalingam Krishnan; Durairaj Sekar; Santha Karunanithy; Sethupathy Subramanium
Journal:  Genes Dis       Date:  2016-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.